175 related articles for article (PubMed ID: 16703801)
1. Interactions between serum creatinine, volume status, N-acetylcysteine, and contrast-induced nephropathy.
Toprak O
Ren Fail; 2006; 28(3):265-6. PubMed ID: 16703801
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL
N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414
[TBL] [Abstract][Full Text] [Related]
3. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?
Tanaka A; Suzuki Y; Suzuki N; Hirai T; Yasuda N; Miki K; Fujita M; Tanaka T
Intern Med; 2011; 50(7):673-7. PubMed ID: 21467697
[TBL] [Abstract][Full Text] [Related]
4. Prevention of contrast-induced nephropathy in vascular surgery patients.
Lawlor DK; Moist L; DeRose G; Harris KA; Lovell MB; Kribs SW; Elliot J; Forbes TL
Ann Vasc Surg; 2007 Sep; 21(5):593-7. PubMed ID: 17823041
[TBL] [Abstract][Full Text] [Related]
5. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
6. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
Merkle M; Sauter M; Argirov M; Wörnle M
Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
[TBL] [Abstract][Full Text] [Related]
8. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine and contrast-induced nephropathy.
Ritz E
N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738
[No Abstract] [Full Text] [Related]
10. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
Feng Y; Huang X; Li L; Chen Z
Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
[TBL] [Abstract][Full Text] [Related]
11. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis.
Bagshaw SM; Ghali WA
BMC Med; 2004 Oct; 2():38. PubMed ID: 15500690
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
Hoffmann U; Banas B; Fischereder M; Krämer BK
Kidney Blood Press Res; 2004; 27(3):161-6. PubMed ID: 15256811
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
[TBL] [Abstract][Full Text] [Related]
14. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.
Guru V; Fremes SE
Clin Nephrol; 2004 Aug; 62(2):77-83. PubMed ID: 15356963
[TBL] [Abstract][Full Text] [Related]
15. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
[TBL] [Abstract][Full Text] [Related]
16. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
[TBL] [Abstract][Full Text] [Related]
17. The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity.
Sandhu C; Belli AM; Oliveira DB
Cardiovasc Intervent Radiol; 2006; 29(3):344-7. PubMed ID: 16502177
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
Shalansky SJ; Vu T; Pate GE; Levin A; Humphries KH; Webb JG
Pharmacotherapy; 2005 Aug; 25(8):1095-103. PubMed ID: 16207100
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.
Liu R; Nair D; Ix J; Moore DH; Bent S
J Gen Intern Med; 2005 Feb; 20(2):193-200. PubMed ID: 15836554
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography.
Traub SJ; Mitchell AM; Jones AE; Tang A; O'Connor J; Nelson T; Kellum J; Shapiro NI
Ann Emerg Med; 2013 Nov; 62(5):511-520.e25. PubMed ID: 23769807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]